Andexanet alfa recommended for reversing anticoagulation from apixaban or rivaroxaban
NICE draft guidance recommends andexanet alfa for reversing anticoagulation in gastrointestinal bleeding, and only in research for intracranial haemorrhage.
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.